Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2113–2136 of 3,979 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Infection, Renal Dysfunction
Interventions: aminoglycoside; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: Up to 18 Years
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 2
States / cities: Louisville, Kentucky • Richmond, Virginia

Conditions: Ovarian Cancer, Sexual Dysfunction
Interventions: questionnaires; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: DOCK8 Deficiency
Interventions: Reduced-intensity hematopoietic stem cell, Fludarabine(Fludara, Berlex Laboratories), Cyclophosphamide(CTX, Cytoxan), Total Body Irradiation (TBI), Busulfan (Busulfex), Donor peripheral blood stem cell mobiliation and collection, Bone Marrow Harvest Procedure; Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 4 Years to 120 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Epilepsy in Children, Executive Dysfunction
Interventions: Epilepsy Journey web-based modules, Telehealth with a therapist; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 17 Years
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 3
States / cities: Orange, California • Cincinnati, Ohio • Charleston, South Carolina

Conditions: ADHD, Attention Deficit Hyperactivity Disorder
Interventions: Methylphenidate Transdermal System, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 12 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Mild Cognitive Impairment, Depression
Interventions: Accelerated iTBS, Sham Comparator; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 60 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hypertension, Cardiovascular Diseases
Interventions: Ascorbic acid solution (American Regent Laboratories Inc.), Saline; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 35 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cognitive Impairment, Dementia, Post ICU Syndrome, Critical Illness, Cognitive Impairment, Mild
Interventions: Usual Care post-Intensive Care Unit (ICU), Anticipating Decline and Providing Therapy (ADAPT); Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Microvascular Coronary Dysfunction
Interventions: Mental Stress Testing, Peripheral Arterial Tonometry (PAT) Testing, Heart Rate Variability (HRV), RESPeRATE Breathing Trial, SPECT cardiac scan with 123I-mIBG and Myoview; Behavioral · Other · Procedure
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: A Program of SUPPORT-D (dementia); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Mild Cognitive Impairment
Interventions: iTBS rTMS; Device
Lead sponsor: Maria I. Lapid, M.D.; Other
Eligibility: 55 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alzheimer Disease, Cognitive Impairment, Mild Cognitive Impairment, Dementia, Mild, Dementia Moderate, Dementia Alzheimers, Dementia of Alzheimer Type, AD
Interventions: Sensory Stimulation System (GS120) - Active; Device
Lead sponsor: Cognito Therapeutics, Inc.; Industry
Eligibility: 50 Years to 92 Years
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 53
States / cities: Phoenix, Arizona • Sun City, Arizona • Anaheim, California + 48 more

Conditions: Meibomian Gland Dysfunction
Interventions: meibomian gland probing, Left eye Meibomian Gland Probing Control Group; Procedure
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Healthy Aging, Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Audiovisual stimulation VR system; Device
Lead sponsor: Clarity Health Technologies, Inc; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Portola Valley, California • Leesburg, Florida

Conditions: Complex Congenital Heart Defect, Dysfunctional RVOT Conduit, Pulmonary Valve Insufficiency, Pulmonary Valve Degeneration
Interventions: SAPIEN 3/SAPIEN 3 Ultra RESILIA THV, SAPIEN 3 THV, SAPIEN 3 Ultra RESILIA THV; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: Not listed
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2031
U.S. locations: 27
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 20 more

Conditions: Chronic Pain, Physical Activity, Older Adults, Mild Cognitive Impairment
Interventions: MBCT+w, ALED; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Postoperative Voiding Dysfunction, Postoperative Urinary Retention
Interventions: Bladder Scanner; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: New York, New York

Conditions: Myocardial Infarction
Interventions: Aliskiren, placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 820 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Novartis US, New Jersey

Conditions: Genito-Pelvic Pain/Penetration Disorder, Dyspareunia, Vaginismus, Pelvic Pain, Vestibulodynia, Vulvodynia (Chronic Vulvar Pain)
Interventions: Pelvic floor therapy; Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Advanced Refractory Left Ventricular Heart Failure
Interventions: HeartMate 3 LVAS, HeartMate II LVAS; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 1,028 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 69
States / cities: Little Rock, Arkansas • Beverly Hills, California • La Jolla, California + 53 more

Conditions: Heart Diseases, Left Ventricular Dysfunction
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Heart Failure
Interventions: Glial growth factor 2/ Neuregulin 1β3, Placebo; Drug · Other
Lead sponsor: Acorda Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Atlanta, Georgia • Nashville, Tennessee

Conditions: Vulvovaginal Atrophy
Interventions: WC3011 Estradiol Vaginal Cream, Vehicle; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 35 Years and older · Female only
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 57
States / cities: Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 48 more

Conditions: Multiple System Atrophy
Interventions: ATH434; Drug
Lead sponsor: Alterity Therapeutics; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children

Sexual Functioning After Primary Treatment of Ovarian Cancer

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy

Study of Medication Patch to Treat Children Ages 6-12 With ADHD

Transcranial Magnetic Stimulation for MCI

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Anticipating Decline and Providing Therapy

Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction

SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers

iTBS rTMS in Mild Cognitive Impairment

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea

The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline

Void Trials After Two Voiding Trials (TVT)

Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

MOMENTUM 3 IDE Clinical Study Protocol

InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

A Biomarker Study of ATH434 in Participants With MSA